The abstract is read at the publisher; the summary is JClub's.
A European-ancestry GWAS of 2366 cholangiocarcinoma cases and 11,750 controls identifies a new genome-wide significant variant, rs535777 (OR=1.44), near HLA-DRB1/DQA1.
- Why it matters: Genetic susceptibility for cholangiocarcinoma and its clinical subtypes is poorly defined, and prior germline GWAS evidence is limited.
- What they did: The study performed GWAS with fine-mapping, functional annotation, and HLA imputation, then ran subtype- and PSC-stratified analyses plus cross-trait LD score regression and Mendelian randomization across multiple traits.
- The result: It finds additional subtype-linked variants (including PSC-related and non-PSC-related signals) and HLA amino-acid residues, and Mendelian randomization supports putative causal associations for 12 traits with CCA or its subtypes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.